Costello Asset Management, Inc Moderna, Inc. Transaction History

Costello Asset Management, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$135.66 - $197.02 $5,426 - $7,880	-40 Reduced 50.0%	40 $6,000
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $9,115 - $16,173	-77 Reduced 49.04%	80 $14,000
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $2,007 - $3,301	17 Added 12.14%	157 $19,000
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $11,713 - $17,659	-100 Reduced 41.67%	140 $20,000
Q1 2022 Apr 26, 2022	BUY	$126.46 - $235.05 $22,130 - $41,133	175 Added 269.23%	240 $41,000
Q4 2021 Jan 28, 2022	SELL	$225.82 - $368.51 $27,098 - $44,221	-120 Reduced 64.86%	65 $17,000
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $13,314 - $29,068	60 Added 48.0%	185 $71,000
Q2 2021 Aug 05, 2021	BUY	$129.91 - $234.98 $9,743 - $17,623	75 Added 150.0%	125 $29,000
Q4 2020 Feb 05, 2021	SELL	$65.74 - $169.86 $3,286 - $8,493	-50 Reduced 50.0%	50 $5,000
Q3 2020 Nov 04, 2020	BUY	$54.34 - $94.85 $5,434 - $9,485	100 New	100 $7,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Costello Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Costello Asset Management, Inc with notifications on news.